Fixed-dose low-molecular-weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: a prospective cohort study - Monreal, M; Zacharski, L; Jiménez, J A; Roncales, J; Vilaseca, B (J Thromb Haemost, 2004)